Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 1/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 1/20 | 1.00 |
| ▸ | TACR2 | P21452 | 1/20 | 1.00 |
| ▸ | DRD1 | P21728 | 1/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 1/20 | 1.00 |
| ▸ | HTR2A | P28223 | 1/20 | 1.00 |
| ▸ | HTR2C | P28335 | 1/20 | 1.00 |
| ▸ | ADORA1 | P30542 | 1/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 1/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 1/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 1/20 | 1.00 |
| ▸ | HTR6 | P50406 | 1/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 1/20 | 1.00 |
| ▸ | GALE | Q14376 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Haloprogin SCHEMBL30128207 | 1.00 | NR1I2 (1.00) | NR1I2ADRA2AADORA3ADRA2BADRA2C | |
| Haloprogin SCHEMBL8165340 | 1.00 | NR1I2 (1.00) | NR1I2ADRA2AADORA3ADRA2BADRA2C | |
| Haloprogin SCHEMBL5528345 | 0.88 | NR1I2 (0.78) | NR1I2ADRA2AADORA3ADRA2BADRA2C | |
| SCHEMBL14529596 | 0.80 | NR1I2 (0.67) | NR1I2ADRA2AADORA3ADRA2BADRA2C | |
| Disulfiram SCHEMBL5306580 | 0.79 | ADRA2A (0.62) | NR1I2ADRA2AADORA3ADRA2BADRA2C | |
| SCHEMBL2641377 | 0.75 | NR1I2 (0.60) | NR1I2ADRA2AADORA3ADRA2BADRA2C | |
| SCHEMBL3737958 | 0.75 | NR1I2 (0.60) | NR1I2ADRA2AADORA3ADRA2BADRA2C | |
| Haloprogin SCHEMBL21327043 | 0.74 | NR1I2 (0.56) | NR1I2ADRA2AADORA3ADRA2BADRA2C | |
| SCHEMBL11307723 | 0.74 | NR1I2 (0.58) | NR1I2ADRA2AADORA3ADRA2BADRA2C | |
| SCHEMBL978758 | 0.69 | NR1I2 (0.52) | NR1I2ADRA2AADORA3ADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9636 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260027140-A1 | COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA | ATOPIC MEDICAL INC (US) | 2026-01-29 | — | — | US | claimed |
| EP-4680240-A1 | METHOD OF TREATING DISORDERS WITH SURF1 MALFUNCTION | Cure Mito Foundation (US) | 2026-01-21 | — | — | EP | claimed |
| EP-4676500-A2 | MICROBIAL CONSORTIA | Kanvas Biosciences, Inc (US) | 2026-01-14 | — | — | EP | claimed |
| US-20250268998-A1 | METHODS OF TREATMENT FOR CANDIDA AURIS INFECTIONS | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 2025-08-28 | — | — | US | claimed |
| US-20250248940-A1 | Biopolymer Formulations for Drug Delivery | 11584022 CANADA INC. (CA) | 2025-08-07 | — | — | US | claimed |
| US-12324830-B2 | Methods of treatment for Candida auris infections | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 2025-06-10 | — | — | US | claimed |
| EP-4547280-A1 | BIOPOLYMER FORMULATIONS FOR DRUG DELIVERY | 11584022 Canada Inc. (CA) | 2025-05-07 | — | — | EP | claimed |
| WO-2025080590-A1 | CO-CRYSTALLIZATION OF ACTIVES WITH SACCHARIDE-BASED MOLECULAR FRAMEWORKS | SCIENTIFIC HORIZONS CONSULTING LLC (US) | 2025-04-17 | — | — | WO | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| US-4895727-A | Using water soluble zinc compound | CHEMEX PHARMACEUTICALS, INC. (US) | 1990-01-23 | — | — | US | claimed |
| EP-0320254-A1 | Aqueous gels containing topical medicaments | THAMES PHARMACAL CO.INC. (US) | 1989-06-14 | — | — | EP | claimed |
| EP-0098743-B1 | PHENYL ALPHA-ACYLOXYACETAMIDE DERIVATES AND THEIR THERAPEUTIC USE | Yu, Ruey J., Dr. (US) | 1988-09-28 | — | — | EP | claimed |
| EP-0273202-A2 | Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots. | Van Scott, Eugene J., Dr. (US) | 1988-07-06 | — | — | EP | claimed |
| EP-0094329-B1 | TANNING PROCESS FOR RENDERING LEATHERS MYCOSTATIC, ANTIMYCOSIC AND ANTIFUNGICIDAL, AND ARTICLES PRODUCED THEREBY | Roux, Joel (FR) | 1986-01-22 | — | — | EP | claimed |
| US-4518789-A | Phenyl alpha-acyloxyacetamide derivatives and their therapeutic use | YU RUEY J | 1985-05-21 | — | — | US | claimed |
| US-4484925-A | USING BIOCIDAL AGENTS ON METAL COMPLEXES | ROUX JOEL (FR) | 1984-11-27 | — | — | US | claimed |
| US-4434183-A | 3-IODO-2-PROPYNYL 2,4,5-TRICHLOROPHENYL ETHER | PENNWALT CORPORATION (US) | 1984-02-28 | — | — | US | claimed |
| EP-0098743-A1 | Phenyl alpha-acyloxyacetamide derivates and their therapeutic use | Yu, Ruey J., Dr. (US) | 1984-01-18 | — | — | EP | claimed |
| EP-0094329-A1 | Tanning process for rendering leathers mycostatic, antimycosic and antifungicidal, and articles produced thereby | Roux, Joel (FR) | 1983-11-16 | — | — | EP | claimed |